HUP0200747A3 - Pharmaceutical compounds and pharmaceutical compositions containing them - Google Patents
Pharmaceutical compounds and pharmaceutical compositions containing themInfo
- Publication number
- HUP0200747A3 HUP0200747A3 HU0200747A HUP0200747A HUP0200747A3 HU P0200747 A3 HUP0200747 A3 HU P0200747A3 HU 0200747 A HU0200747 A HU 0200747A HU P0200747 A HUP0200747 A HU P0200747A HU P0200747 A3 HUP0200747 A3 HU P0200747A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical
- compositions containing
- compounds
- pharmaceutical compositions
- pharmaceutical compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI000750A IT1311921B1 (en) | 1999-04-13 | 1999-04-13 | PHARMACEUTICAL COMPOUNDS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200747A2 HUP0200747A2 (en) | 2002-06-29 |
| HUP0200747A3 true HUP0200747A3 (en) | 2003-02-28 |
Family
ID=11382682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200747A HUP0200747A3 (en) | 1999-04-13 | 2000-04-11 | Pharmaceutical compounds and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1192129A2 (en) |
| JP (1) | JP2002541242A (en) |
| KR (1) | KR20020005671A (en) |
| CN (1) | CN1356981A (en) |
| AU (1) | AU3820000A (en) |
| BR (1) | BR0009701A (en) |
| CA (1) | CA2370406A1 (en) |
| HU (1) | HUP0200747A3 (en) |
| IL (1) | IL145632A0 (en) |
| IT (1) | IT1311921B1 (en) |
| MX (1) | MXPA01010209A (en) |
| NO (1) | NO20014926L (en) |
| PL (1) | PL351241A1 (en) |
| TR (1) | TR200102939T2 (en) |
| WO (1) | WO2000061549A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1311924B1 (en) * | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
| IL150368A0 (en) | 1999-12-23 | 2002-12-01 | Nitromed Inc | Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use |
| AU7007001A (en) | 2000-06-22 | 2002-01-02 | Nitromed Inc | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| US6706724B2 (en) | 2000-12-21 | 2004-03-16 | Nitromed, Inc. | Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| ATE437637T1 (en) | 2001-05-02 | 2009-08-15 | Nitromed Inc | NITROZED AND NITROSYLATED NEBIVOLOL AND ITS METABOLITES, COMPOSITIONS AND METHODS OF USE |
| CA2487414A1 (en) | 2002-06-11 | 2003-12-18 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| AU2003279622A1 (en) | 2002-06-28 | 2004-01-19 | Nitromed, Inc. | Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| JP2005539089A (en) | 2002-07-03 | 2005-12-22 | ニトロメッド インコーポレーティッド | Nitrosated non-steroidal anti-inflammatory compounds, compositions and methods of use |
| JP2005538110A (en) | 2002-07-29 | 2005-12-15 | ニトロメッド インコーポレーティッド | Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| US20040191803A1 (en) * | 2002-11-22 | 2004-09-30 | Michela Gallagher | Target for therapy of cognitive impairment |
| US20090131342A1 (en) * | 2004-01-22 | 2009-05-21 | Nitromed, Inc. | Nitrosated and/or nitrosylated compounds, compositions and methods of use |
| KR100678287B1 (en) | 2005-06-23 | 2007-02-02 | 한미약품 주식회사 | Method for preparing clopidogrel and intermediates used therein |
| CN100404543C (en) * | 2006-09-21 | 2008-07-23 | 浙江海正药业股份有限公司 | A kind of intermediate of synthesizing pirinomycin and its preparation method and application |
| NZ595727A (en) * | 2009-04-17 | 2013-11-29 | Vidasym Inc | Vitamin d receptor agonists and uses thereof |
| US9598383B2 (en) * | 2013-06-26 | 2017-03-21 | The Regents Of The University Of California | Reactive oxygen species-based prodrugs |
| CN107418989A (en) * | 2017-08-21 | 2017-12-01 | 浙江工业大学 | A kind of method of lipase-catalyzed online synthesis N (5 sucrose ester valeryl) metoprolol |
| CN113209065B (en) * | 2021-03-29 | 2023-06-20 | 中国科学院西北高原生物研究所 | Use of alkaloid compound in the preparation of products for preventing and/or treating heart damage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1134458B (en) * | 1980-11-26 | 1986-08-13 | Real Sas Di Alberto Reiner | N-ACETYL-CISTEIN DERIVATIVE FOR THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS |
| IT1190987B (en) * | 1982-09-07 | 1988-02-24 | Pharma Edmond Srl | ACETYLSALICYLIC ACID THIOESTERS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| ES8609231A1 (en) * | 1985-12-03 | 1986-09-01 | Farmhispania | Antiinflammatory N-acetyl-benzoyl-mercapto-alanine prepn. |
| IT1213301B (en) * | 1986-07-14 | 1989-12-20 | Zambon Spa | COMPOSITIONS FOR THE TREATMENT OF SYNDROMES FROM ISCHEMIA AND REPERFUSION |
| EP0971743B1 (en) * | 1997-04-18 | 2006-07-12 | Fritz Stanislaus | Stabilized medicaments containing cysteinyl derivatives |
-
1999
- 1999-04-13 IT IT1999MI000750A patent/IT1311921B1/en active
-
2000
- 2000-04-11 TR TR2001/02939T patent/TR200102939T2/en unknown
- 2000-04-11 CN CN00808855A patent/CN1356981A/en active Pending
- 2000-04-11 JP JP2000610825A patent/JP2002541242A/en active Pending
- 2000-04-11 PL PL00351241A patent/PL351241A1/en not_active Application Discontinuation
- 2000-04-11 IL IL14563200A patent/IL145632A0/en unknown
- 2000-04-11 WO PCT/EP2000/003237 patent/WO2000061549A2/en not_active Ceased
- 2000-04-11 KR KR1020017012971A patent/KR20020005671A/en not_active Withdrawn
- 2000-04-11 BR BR0009701-2A patent/BR0009701A/en not_active IP Right Cessation
- 2000-04-11 EP EP00917074A patent/EP1192129A2/en not_active Withdrawn
- 2000-04-11 MX MXPA01010209A patent/MXPA01010209A/en unknown
- 2000-04-11 HU HU0200747A patent/HUP0200747A3/en unknown
- 2000-04-11 AU AU38200/00A patent/AU3820000A/en not_active Abandoned
- 2000-04-11 CA CA002370406A patent/CA2370406A1/en not_active Abandoned
-
2001
- 2001-10-10 NO NO20014926A patent/NO20014926L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3820000A (en) | 2000-11-14 |
| IT1311921B1 (en) | 2002-03-20 |
| WO2000061549A3 (en) | 2002-01-03 |
| KR20020005671A (en) | 2002-01-17 |
| IL145632A0 (en) | 2002-06-30 |
| BR0009701A (en) | 2002-04-02 |
| NO20014926L (en) | 2001-12-13 |
| HUP0200747A2 (en) | 2002-06-29 |
| MXPA01010209A (en) | 2003-07-21 |
| EP1192129A2 (en) | 2002-04-03 |
| CA2370406A1 (en) | 2000-10-19 |
| PL351241A1 (en) | 2003-04-07 |
| WO2000061549A2 (en) | 2000-10-19 |
| NO20014926D0 (en) | 2001-10-10 |
| JP2002541242A (en) | 2002-12-03 |
| CN1356981A (en) | 2002-07-03 |
| TR200102939T2 (en) | 2002-09-23 |
| ITMI990750A1 (en) | 2000-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
| IL148489A0 (en) | Quinazoline compounds and pharmaceutical compositions containing them | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| IL144910A0 (en) | Cyclic compounds and pharmaceutical compositions containing the same | |
| IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| PL351387A1 (en) | Pharmaceutical composition | |
| HUP0202513A3 (en) | Betha-carboline pharmaceutical compositions | |
| ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
| IL149883A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| HUP0103256A3 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds | |
| IL147970A0 (en) | Pharmaceutical compositions containing tripeptides | |
| GB0001662D0 (en) | Pharmaceutical compositions | |
| GB0028088D0 (en) | Pharmaceutical compositions | |
| IL143841A0 (en) | Amide compounds and pharmaceutical compositions containing the same | |
| HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
| HUP0104657A3 (en) | Imidazole compounds and pharmaceutical compositions containing them | |
| GB9923436D0 (en) | Pharmaceutical compositions | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| HUP0202255A3 (en) | Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them | |
| HUP0201714A3 (en) | Substituted heterocyclic compounds and pharmaceutical compositions containing them | |
| HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
| HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same |